Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Tumor targeting effects of a novel modified paclitaxel-loaded discoidal mimic high density lipoproteins.

Wang J, Jia J, Liu J, He H, Zhang W, Li Z.

Drug Deliv. 2013 Nov;20(8):356-63. doi: 10.3109/10717544.2013.834418. Epub 2013 Sep 30.

PMID:
24079327
2.

Arachidonic acid-modified lovastatin discoidal reconstituted high density lipoprotein markedly decreases the drug leakage during the remodeling behaviors induced by lecithin cholesterol acyltransferase.

He H, Liu L, Bai H, Wang J, Zhang Y, Zhang W, Zhang M, Wu Z, Liu J.

Pharm Res. 2014 Jul;31(7):1689-709. doi: 10.1007/s11095-013-1273-3. Epub 2014 Jan 22.

PMID:
24449440
3.

Preparation, characterizations, and in vitro metabolic processes of paclitaxel-loaded discoidal recombinant high-density lipoproteins.

Jia J, Xiao Y, Liu J, Zhang W, He H, Chen L, Zhang M.

J Pharm Sci. 2012 Aug;101(8):2900-8. doi: 10.1002/jps.23210. Epub 2012 May 24.

PMID:
22628199
4.

Pharmacokinetics and atherosclerotic lesions targeting effects of tanshinone IIA discoidal and spherical biomimetic high density lipoproteins.

Zhang W, He H, Liu J, Wang J, Zhang S, Zhang S, Wu Z.

Biomaterials. 2013 Jan;34(1):306-19. doi: 10.1016/j.biomaterials.2012.09.058. Epub 2012 Oct 13.

PMID:
23069716
5.

Structure and remodeling behavior of drug-loaded high density lipoproteins and their atherosclerotic plaque targeting mechanism in foam cell model.

Zhang WL, Xiao Y, Liu JP, Wu ZM, Gu X, Xu YM, Lu H.

Int J Pharm. 2011 Oct 31;419(1-2):314-21. doi: 10.1016/j.ijpharm.2011.07.039. Epub 2011 Jul 30.

PMID:
21835236
7.

Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier.

Mooberry LK, Nair M, Paranjape S, McConathy WJ, Lacko AG.

J Drug Target. 2010 Jan;18(1):53-8. doi: 10.3109/10611860903156419.

PMID:
19637935
8.
10.

Evaluation of synthetic/reconstituted high-density lipoproteins as delivery vehicles for paclitaxel.

McConathy WJ, Nair MP, Paranjape S, Mooberry L, Lacko AG.

Anticancer Drugs. 2008 Feb;19(2):183-8. doi: 10.1097/CAD.0b013e3282f1da86.

PMID:
18176115
11.
14.

Anti-tumor activity of paclitaxel through dual-targeting lipoprotein-mimicking nanocarrier.

Chen C, Hu H, Qiao M, Zhao X, Wang Y, Chen K, Chen D.

J Drug Target. 2015 May;23(4):311-22. doi: 10.3109/1061186X.2014.994182. Epub 2014 Dec 24.

PMID:
25539074
15.

Regulation of reconstituted high density lipoprotein structure and remodeling by apolipoprotein E.

Rye KA, Bright R, Psaltis M, Barter PJ.

J Lipid Res. 2006 May;47(5):1025-36. Epub 2006 Feb 1.

16.

Comparative evaluation of novel biodegradable nanoparticles for the drug targeting to breast cancer cells.

Mattu C, Pabari RM, Boffito M, Sartori S, Ciardelli G, Ramtoola Z.

Eur J Pharm Biopharm. 2013 Nov;85(3 Pt A):463-72. doi: 10.1016/j.ejpb.2013.07.016. Epub 2013 Aug 1.

PMID:
23916461
17.

Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants.

Jonas A, von Eckardstein A, K├ęzdy KE, Steinmetz A, Assmann G.

J Lipid Res. 1991 Jan;32(1):97-106.

19.

Tumor-targeting and pH-sensitive lipoprotein-mimic nanocarrier for targeted intracellular delivery of paclitaxel.

Chen C, Hu H, Qiao M, Zhao X, Wang Y, Chen K, Guo X, Chen D.

Int J Pharm. 2015 Mar 1;480(1-2):116-27. doi: 10.1016/j.ijpharm.2015.01.036. Epub 2015 Jan 20.

PMID:
25615984
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk